Patents by Inventor Lorin Johnson

Lorin Johnson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FORMULATION
    Publication number: 20220119819
    Abstract: The present invention relates to a new formulation of the oligonucleotide of SEQ ID NO: 1.
    Type: Application
    Filed: January 6, 2022
    Publication date: April 21, 2022
    Inventors: Toby Wilson Waterworth, Lorin Johnson, Janette Thomas, Michael Webb
  • Formulation
    Patent number: 11220690
    Abstract: The present invention relates to a new formulation of the oligonucleotide of SEQ ID NO:1.
    Type: Grant
    Filed: January 8, 2018
    Date of Patent: January 11, 2022
    Assignee: Atlantic Pharmaceuticals (Holdings) LTD
    Inventors: Toby Wilson Waterworth, Lorin Johnson, Janette Thomas, Michael Webb
  • NEW THERAPEUTIC USES
    Publication number: 20190388459
    Abstract: The present invention related to a new therapeutic uses the molecule set out as SEQ ID NO: 1.
    Type: Application
    Filed: January 8, 2018
    Publication date: December 26, 2019
    Inventors: Toby Waterworth, Lorin Johnson, Janette Thomas, Michael Webb
  • NEW FORMULATION
    Publication number: 20190367927
    Abstract: The present invention relates to a new formulation of the oligonucleotide of SEQ ID NO:1.
    Type: Application
    Filed: January 8, 2018
    Publication date: December 5, 2019
    Inventors: Toby Wilson Waterworth, Lorin Johnson, Janette Thomas, Michael Webb
  • Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
    Patent number: 9192616
    Abstract: A method of increasing the bioavailability of balsalazide by administration of an oral dosage form with food is provided, as well as an article of manufacture comprising an oral dosage form of balsalazide in a suitable container and associated with printed labeling which describes the increased bioavailability of the medication in the container when taken with food.
    Type: Grant
    Filed: April 4, 2012
    Date of Patent: November 24, 2015
    Assignee: Salix Pharmaceuticals, Inc.
    Inventor: Lorin Johnson
  • Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
    Patent number: 8921344
    Abstract: A method of increasing the bioavailability of 5-aminosalicylate compound by administration of an oral dosage form with food is provided, as well as an article of manufacture comprising an oral dosage form of 5-aminosalicylate compound in a suitable container and associated with printed labeling which describes the increased bioavailability of the medication in the container when taken with food.
    Type: Grant
    Filed: November 3, 2006
    Date of Patent: December 30, 2014
    Assignee: Salix Pharmaceuticals, Inc.
    Inventor: Lorin Johnson
  • Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males
    Patent number: 8497256
    Abstract: The instant application provides methods and compositions for the treatment of male subjects having ulcerative colitis.
    Type: Grant
    Filed: April 26, 2011
    Date of Patent: July 30, 2013
    Assignee: Salix Pharmaceuticals, Ltd
    Inventors: William Forbes, Enoch Bortey, Lorin Johnson
  • METHODS OF TREATING BOWEL DISEASES BY ADMINISTERING A BOWEL CLEANSER AND AN ANTIBIOTIC
    Publication number: 20130164384
    Abstract: The present invention relates to formulations and kits for the treatment of bowel disease, to their use in medicinal preparations and to therapeutic methods thereof.
    Type: Application
    Filed: September 5, 2012
    Publication date: June 27, 2013
    Applicant: Salix Pharmaceuticals, Ltd.
    Inventors: Lorin Johnson, William Forbes, Stephana Patton
  • METHODS FOR TREATING BOWEL DISEASES
    Publication number: 20130137713
    Abstract: The present invention provides new methods of treating bowel disease (BD) by increasing a durability of response; treating BD in males; treating BD in adolescent subjects; treating bloating due to BD in males; and methods of maintaining remission of BD.
    Type: Application
    Filed: October 12, 2012
    Publication date: May 30, 2013
    Inventors: William Forbes, Lorin Johnson
  • FORMULATIONS AND USES OF 2-HYDROXY-5-PHENYLAZOBENZOIC ACID DERIVATIVES
    Publication number: 20130065862
    Abstract: A method of increasing the bioavailability of balsalazide by administration of an oral dosage form with food is provided, as well as an article of manufacture comprising an oral dosage form of balsalazide in a suitable container and associated with printed labeling which describes the increased bioavailability of the medication in the container when taken with food.
    Type: Application
    Filed: April 4, 2012
    Publication date: March 14, 2013
    Applicant: Salix Pharmaceuticals, Inc.
    Inventor: Lorin Johnson
  • Methods for treating diarrhea-associated irritable bowel syndrome
    Patent number: 8309569
    Abstract: The present invention provides methods of treating diarrhea-associated irritable bowel syndrome (IBS-D) following rifaximin administration.
    Type: Grant
    Filed: February 26, 2009
    Date of Patent: November 13, 2012
    Assignee: Salix Pharmaceuticals, Ltd.
    Inventors: William Forbes, Lorin Johnson
  • FORMULATIONS AND USES OF 2-HYDROXY-5-PHENYLAZOBENZOIC ACID DERIVATIVES FOR THE TREATMENT OF MALES
    Publication number: 20120058184
    Abstract: The instant application provides methods and compositions for the treatment of male subjects having ulcerative colitis.
    Type: Application
    Filed: April 26, 2011
    Publication date: March 8, 2012
    Applicant: SALIX PHARMACEUTICALS, LTD.
    Inventors: William Forbes, Enoch Bortey, Lorin Johnson
  • METHODS FOR TREATING BOWEL DISEASES
    Publication number: 20110118295
    Abstract: The present invention provides new methods of treating bowel disease (BD) by increasing a durability of response; treating BD in males; treating BD in adolescent subjects; treating bloating due to BD in males; and methods of maintaining remission of BD.
    Type: Application
    Filed: February 26, 2009
    Publication date: May 19, 2011
    Applicant: SALIX PHARMACEUTICALS, LTD.
    Inventors: William Forbes, Lorin Johnson
  • NOVEL THERAPEUTIC TARGETS IN INFLAMMATORY BOWEL DISEASE
    Publication number: 20110055943
    Abstract: The present invention relates to novel sequences for use in detection, diagnosis and treatment of bowl disease (BD). The invention provides BD-associated polynucleotide sequences whose expression is associated with BD. Provided herein are diagnostic compositions and methods for the detection of BD. The present invention provides monoclonal and polyclonal antibodies specific for the BD polypeptides. The present invention also provides diagnostic tools and therapeutic compositions and methods for screening, prevention and treatment of BD.
    Type: Application
    Filed: October 16, 2008
    Publication date: March 3, 2011
    Applicant: SALIX PHARMACEUTICALS, LTD.
    Inventors: Frank J. Gonzalez, Lorin Johnson, Xiaochao Ma
  • FORMULATIONS AND USES OF 2-HYDROXY-5-PHENYLAZOBENZOIC ACID DERIVATIVES
    Publication number: 20100087401
    Abstract: A method of increasing the bioavailability of balsalazide by administration of an oral dosage form with food is provided, as well as an article of manufacture comprising an oral dosage form of balsalazide in a suitable container and associated with printed labeling which describes the increased bioavailability of the medication in the container when taken with food.
    Type: Application
    Filed: November 30, 2009
    Publication date: April 8, 2010
    Applicant: SALIX PHARMACEUTICALS, LTD.
    Inventor: Lorin Johnson
  • METHODS OF TREATING BOWEL DISEASES BY ADMINISTERING A BOWEL CLEANSER AND AN ANTIBIOTIC
    Publication number: 20090324736
    Abstract: The present invention relates to formulations and kits for the treatment of bowel disease, to their use in medicinal preparations and to therapeutic methods thereof.
    Type: Application
    Filed: May 7, 2009
    Publication date: December 31, 2009
    Applicant: Salix Pharmaceuticals, Ltd.
    Inventors: Lorin Johnson, William Forbes, Stephana Patton
  • Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
    Patent number: 7625884
    Abstract: A method of increasing the bioavailability of balsalazide by administration of an oral dosage form with food is provided, as well as an article of manufacture comprising an oral dosage form of balsalazide in a suitable container and associated with printed labeling which describes the increased bioavailability of the medication in the container when taken with food.
    Type: Grant
    Filed: October 23, 2007
    Date of Patent: December 1, 2009
    Assignee: Salix Pharmaceuticals, Ltd
    Inventor: Lorin Johnson
  • Balsalazide formulations and manufacture and use thereof
    Publication number: 20090252788
    Abstract: The invention relates to formulations and dosage schedules of balsalazide. The invention further relates to methods of producing pharmaceutical formulations of balsalazide.
    Type: Application
    Filed: February 22, 2008
    Publication date: October 8, 2009
    Applicant: Salix Pharmaceuticals, Inc.
    Inventors: Joseph Lockhart, Brock Swanson, Lorin Johnson
  • Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
    Patent number: 7452872
    Abstract: A method of increasing the bioavailability of balsalazide by administration of an oral dosage form with food is provided, as well as an article of manufacture comprising an oral dosage form of balsalazide in a suitable container and associated with printed labeling which describes the increased bioavailability of the medication in the container when taken with food.
    Type: Grant
    Filed: August 8, 2007
    Date of Patent: November 18, 2008
    Assignee: Salix Pharmaceuticals, Inc.
    Inventor: Lorin Johnson
  • FORMULATIONS AND USES OF 2-HYDROXY-5-PHENYLAZOBENZOIC ACID DERIVATIVES
    Publication number: 20080096849
    Abstract: A method of increasing the bioavailability of balsalazide by administration of an oral dosage form with food is provided, as well as an article of manufacture comprising an oral dosage form of balsalazide in a suitable container and associated with printed labeling which describes the increased bioavailability of the medication in the container when taken with food.
    Type: Application
    Filed: October 23, 2007
    Publication date: April 24, 2008
    Applicant: Salix Pharmaceuticals, Inc.
    Inventor: Lorin Johnson